Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
5460.17%
↑ 829% above average
Average (9y)
587.52%
Historical baseline
Range
High:5460.17%
Low:-97.87%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 5460.17% |
| 2023 | -97.87% |
| 2022 | 11.88% |
| 2021 | -58.09% |
| 2020 | 11.57% |
| 2019 | 1.41% |
| 2018 | 88.50% |
| 2017 | -38.59% |
| 2016 | 534.48% |
| 2015 | -38.30% |